Oxalic Acid

Oxalic Acid

SCHEMBL4228878

NCCCCCCN1CCc2ccccc2C1.O=C(O)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 known ✓ P31645 1/20 0.61
▸ HTR7 P34969 11/20 0.65
▸ HDAC3 O15379 1/20 0.62
▸ HDAC1 Q13547 1/20 0.62
▸ HDAC2 Q92769 1/20 0.62
▸ HDAC8 Q9BY41 1/20 0.62
▸ NCOR2 Q9Y618 1/20 0.62
▸ HTR1A P08908 6/20 0.61
▸ DRD3 P35462 5/20 0.61
▸ DRD2 P14416 4/20 0.61
▸ HTR2A P28223 3/20 0.61
▸ HTR2B P41595 3/20 0.61
▸ HRH1 P35367 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27921604 0.91 HTR7 (0.62) HTR7HDAC3HDAC1HDAC2HDAC8
SCHEMBL4225899 0.91 HTR7 (0.62) HTR7HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL4224101 0.90 HTR7 (0.61) HTR7HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL4231322 0.90 HTR7 (0.61) HTR7HDAC3HDAC1HDAC2HDAC8
SCHEMBL4229926 0.90 HTR7 (0.64) HTR7HDAC3HDAC1HDAC2HDAC8
Fumaric Acid SCHEMBL4232356 0.89 HTR7 (0.62) HTR7HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL4224319 0.88 HTR7 (0.62) HTR7HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL4222983 0.88 HTR7 (0.62) HTR7HDAC3HDAC1HDAC2HDAC8
Oxalic Acid SCHEMBL4228870 0.88 HDAC3 (0.68) HTR7HDAC3HDAC1HDAC2HDAC8
SCHEMBL2795026 0.85 HTR7 (0.63) HTR7HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188115-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-05-29 — — US disclosed
US-20090163542-A1 5-ht7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-06-25 — — US disclosed
US-7211585-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-05-01 — — US disclosed
US-20060040978-A1 5-HT7 receptor antagonists LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163542-A1 5-ht7 receptor antagonists HTR7, HTR1A, HTR5A SLC6A4 20/4885HTR7 1/4885HDAC3 2350/4885
US-20060040978-A1 5-HT7 receptor antagonists HTR7, HTR1A, HTR5A SLC6A4 20/4885HTR7 1/4885HDAC3 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback